Share on facebook Share on Twitter Share on Google Plus Share This
Back to Results

Christine Lundquist, MPH


Training + Education Boston University School of Public Health; Psychology, University of Pennsylvania
Gender Female
Accepted Insurances View Accepted Insurances at Tufts MC + Floating Hospital

Publications + National Presentations

1. Mizock L, Lundquist C. Therapy missteps with transgender clients: promoting gender sensitivity in clinical work. Submitted to Psychology of Sexual Orientation and Gender Diversity (under review).

2. Mizock L, Lundquist C, Hopwood R, Merryman M. Coping with transphobia to promote resilience among transgender individuals. Paper presentation. American Psychological Association Annual Convention, Washington, DC, 2014.

3. Campos S, Berlin S, Lundquist C, Roche M, Whalen C, Horowitz N, Penson R. A phase I study of AZD2171 and Temsirolimus in advanced GYN cancers. Abstracts of Gynecologic Oncology, 2012:125. Abstract 188.


Christine Lundquist, MPH is a Research Assistant in the Predictive Analytics and Comparative Effectiveness (PACE) Center at Tufts Medical Center. She is responsible for database creation and management, grant applications and progress reports, data analysis, manuscript drafting, and general project management. Her current projects include the Clinical Prediction Model (CPM) Registry and Personalized Risk Information in Cost Effectiveness Studies (PRICES).

Christine has several years of experience in research. She earned a BA in Psychology at the University of Pennsylvania, where she assisted in research on substance abuse, sleep and chronobiology, and environmental reproductive toxicology. She received a Master of Public Health with a concentration in Social and Behavioral Sciences from Boston University, where her main research projects focused on dating violence, transgender mental health, and postpartum depression. Prior to joining the PACE Center in 2015, Christine worked in the Gynecologic Oncology Program at Dana-Farber Cancer Institute, coordinating therapeutic clinical trials and minimal risk studies for patients with gynecologic malignancies. What brought her to PACE is her interest in studying how research results are translated to clinical practice, policy change, and public health interventions.